{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T16:13:44Z","timestamp":1791735224260,"version":"4.3.4"},"reference-count":186,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":43,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.tmaid.2020.101946","type":"journal-article","created":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T03:24:58Z","timestamp":1607397898000},"page":"101946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Typhoid fever infection \u2013 Antibiotic resistance and vaccination strategies: A narrative review"],"prefix":"10.1016","volume":"40","author":[{"given":"Cristina","family":"Masuet-Aumatell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Atouguia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.tmaid.2020.101946_bib1","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra020201","article-title":"Typhoid fever","volume":"347","author":"Parry","year":"2002","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.tmaid.2020.101946_bib2","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1128\/CMR.00002-15","article-title":"Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive Salmonella infections","volume":"28","author":"Crump","year":"2015","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"10.1016\/j.tmaid.2020.101946_bib3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1473-3099(05)70239-5","article-title":"Typhoid and paratyphoid fever in travellers","volume":"5","author":"Connor","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.tmaid.2020.101946_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2310\/7060.2005.12507","article-title":"Enteric fever in Israeli travelers: a nationwide study","volume":"12","author":"Meltzer","year":"2005","journal-title":"J Trav Med"},{"issue":"2","key":"10.1016\/j.tmaid.2020.101946_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa051331","article-title":"Spectrum of disease and relation to place of exposure among ill returned travelers","volume":"354","author":"Freedman","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.tmaid.2020.101946_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2310\/7060.2005.12405","article-title":"Risk of travel-associated typhoid and paratyphoid fevers in various regions","volume":"12","author":"Ekdahl","year":"2005","journal-title":"J Trav Med"},{"issue":"16","key":"10.1016\/j.tmaid.2020.101946_bib7","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJMp1803926","article-title":"Extensively drug-resistant typhoid - are conjugate vaccines arriving just in time?","volume":"379","author":"Andrews","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.tmaid.2020.101946_bib8","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ng.3281","article-title":"Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events","volume":"47","author":"Wong","year":"2015","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.tmaid.2020.101946_bib9","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.01.010401","article-title":"Typhoid fever and paratyphoid fever: systematic review to estimate global morbidity and mortality for 2010","volume":"2","author":"Buckle","year":"2012","journal-title":"J Glob Health"},{"issue":"9973","key":"10.1016\/j.tmaid.2020.101946_bib10","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0140-6736(13)62708-7","article-title":"Typhoid fever","volume":"385","author":"Wain","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2020.101946_bib11","first-page":"Cd001261","article-title":"Vaccines for preventing typhoid fever","volume":"5","author":"Milligan","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"10.1016\/j.tmaid.2020.101946_bib12","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/cid\/civ976","article-title":"Challenges and opportunities for typhoid fever control: a call for coordinated action","volume":"62","author":"Steele","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.tmaid.2020.101946_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005376","article-title":"The burden of typhoid fever in low- and middle-income countries: a meta-regression approach","volume":"11","author":"Antillon","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"10.1016\/j.tmaid.2020.101946_bib14","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1016\/S2214-109X(14)70301-8","article-title":"Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment","volume":"2","author":"Mogasale","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"Suppl 1","key":"10.1016\/j.tmaid.2020.101946_bib15","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/cid\/civ675","article-title":"What have we learned from the typhoid fever surveillance in Africa Program?","volume":"62","author":"Baker","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.tmaid.2020.101946_bib16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1473-3099(18)30685-6","article-title":"The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017","volume":"19","author":"GBD 2017 Typhoid","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.tmaid.2020.101946_bib17","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/S2214-109X(17)30022-0","article-title":"Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study","volume":"5","author":"Marks","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"9487","key":"10.1016\/j.tmaid.2020.101946_bib18","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0140-6736(05)67181-4","article-title":"Typhoid and paratyphoid fever","volume":"366","author":"Bhan","year":"2005","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.tmaid.2020.101946_bib19","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.tim.2014.06.007","article-title":"Salmonella chronic carriage: epidemiology, diagnosis, and gallbladder persistence","volume":"22","author":"Gunn","year":"2014","journal-title":"Trends Microbiol"},{"issue":"6","key":"10.1016\/j.tmaid.2020.101946_bib20","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/infdis\/146.6.724","article-title":"Precise estimation of the numbers of chronic carriers of Salmonella typhi in Santiago, Chile, an endemic area","volume":"146","author":"Levine","year":"1982","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.tmaid.2020.101946_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/inf.1983.15.issue-1.04","article-title":"Biliary calculi in chronic Salmonella carriers and healthy controls: a controlled study","volume":"15","author":"Schioler","year":"1983","journal-title":"Scand J Infect Dis"},{"issue":"14","key":"10.1016\/j.tmaid.2020.101946_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00774-18","article-title":"Pathoadaptive alteration of Salmonella biofilm formation in response to the gallbladder environment","volume":"201","author":"Neiger","year":"2019","journal-title":"J Bacteriol"},{"issue":"9","key":"10.1016\/j.tmaid.2020.101946_bib23","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1128\/JB.188.9.3219-3227.2006","article-title":"Thin aggregative fimbriae and cellulose enhance long-term survival and persistence of Salmonella","volume":"188","author":"White","year":"2006","journal-title":"J Bacteriol"},{"issue":"2","key":"10.1016\/j.tmaid.2020.101946_bib24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.15585\/mmwr.mm6802a5","article-title":"Notes from the field: typhoid fever outbreak - Harare, Zimbabwe","volume":"68","author":"N\u2019Cho","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.tmaid.2020.101946_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s41043-015-0037-6","article-title":"High prevalence of typhoidal Salmonella enterica serovars excreting food handlers in Karachi-Pakistan: a probable factor for regional typhoid endemicity","volume":"33","author":"Siddiqui","year":"2015","journal-title":"J Health Popul Nutr"},{"key":"10.1016\/j.tmaid.2020.101946_bib26","doi-asserted-by":"crossref","first-page":"9589208","DOI":"10.1155\/2018\/9589208","article-title":"Estimating typhoid fever risk associated with lack of access to safe water: a systematic literature review","volume":"2018","author":"Mogasale","year":"2018","journal-title":"J Environ Public Health"},{"key":"10.1016\/j.tmaid.2020.101946_bib27","author":"World Health Organization"},{"issue":"78","key":"10.1016\/j.tmaid.2020.101946_bib28","first-page":"509","article-title":"Diagnostic difficulties in febrile travellers returning from the tropics. Two cases of typhoid fever imported from India","volume":"13","author":"Kacprzak","year":"2002","journal-title":"Pol Merkur Lek"},{"key":"10.1016\/j.tmaid.2020.101946_bib29","author":"Public Health England"},{"issue":"1","key":"10.1016\/j.tmaid.2020.101946_bib30","doi-asserted-by":"crossref","first-page":"E56","DOI":"10.9778\/cmajo.20120012","article-title":"Salmonella enterica serotype Typhi infections in a Canadian pediatric hospital: a retrospective case series","volume":"1","author":"Comeau","year":"2013","journal-title":"CMAJ Open"},{"key":"10.1016\/j.tmaid.2020.101946_bib31","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.tmaid.2020.101946_bib32","author":"Koch Institute"},{"key":"10.1016\/j.tmaid.2020.101946_bib33","author":"European Centre for Disease Prevention and Control"},{"key":"10.1016\/j.tmaid.2020.101946_bib34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12879-016-1479-1","article-title":"Improving the uptake of pre-travel health advice amongst migrant Australians: exploring the attitudes of primary care providers and migrant community groups","volume":"16","author":"Seale","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101946_bib35","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/s12879-015-1159-6","article-title":"Typhoid fever cases in the U.S. military","volume":"15","author":"Sorrell","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.tmaid.2020.101946_bib36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/jtm.12076","article-title":"Typhoid vaccination for international travelers from Greece visiting developing countries","volume":"21","author":"Smeti","year":"2014","journal-title":"J Trav Med"},{"issue":"2","key":"10.1016\/j.tmaid.2020.101946_bib37","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1086\/421945","article-title":"Typhoid fever in travelers: who should be targeted for prevention?","volume":"39","author":"Steinberg","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101946_bib38","first-page":"Cd008892","article-title":"Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever","volume":"5","author":"Wijedoru","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.tmaid.2020.101946_bib39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/medicina54020023","article-title":"Typhoid fever diagnosis in endemic countries: a clog in the wheel of progress?","volume":"54","author":"Ajibola","year":"2018","journal-title":"Medicina"},{"key":"10.1016\/j.tmaid.2020.101946_bib40","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1186\/1756-0500-7-653","article-title":"A comparative study of Widal test with blood culture in the diagnosis of typhoid fever in febrile patients","volume":"7","author":"Andualem","year":"2014","journal-title":"BMC Res Notes"},{"issue":"5","key":"10.1016\/j.tmaid.2020.101946_bib41","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1128\/JCM.42.5.1885-1889.2004","article-title":"Evaluation of rapid diagnostic tests for typhoid fever","volume":"42","author":"Olsen","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tmaid.2020.101946_bib42","first-page":"9042125","article-title":"Baseline antibody titre against Salmonella enterica in healthy population of Mumbai, Maharashtra, India","volume":"2017","author":"Patki","year":"2017","journal-title":"Internet J Microbiol"},{"issue":"1","key":"10.1016\/j.tmaid.2020.101946_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00105-18","article-title":"Emergence of an extensively drug-resistant Salmonella enterica serovar typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins","volume":"9","author":"Klemm","year":"2018","journal-title":"mBio"},{"issue":"9","key":"10.1016\/j.tmaid.2020.101946_bib44","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2471\/BLT.11.087627","article-title":"Sensitivity and specificity of typhoid fever rapid antibody tests for laboratory diagnosis at two sub-Saharan African sites","volume":"89","author":"Keddy","year":"2011","journal-title":"Bull World Health Organ"},{"issue":"4","key":"10.1016\/j.tmaid.2020.101946_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004558","article-title":"Comparison of the performance of the TPTest, Tubex, Typhidot and Widal immunodiagnostic assays and blood cultures in detecting patients with typhoid fever in Bangladesh, including using a bayesian latent class modeling approach","volume":"10","author":"Islam","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"10.1016\/j.tmaid.2020.101946_bib46","first-page":"3","article-title":"New advances in the diagnosis of typhoid and detection of typhoid carriers","volume":"7","author":"Ismail","year":"2000","journal-title":"Malays J Med Sci"},{"issue":"Suppl 3","key":"10.1016\/j.tmaid.2020.101946_bib47","doi-asserted-by":"crossref","first-page":"C21","DOI":"10.1016\/j.vaccine.2015.03.102","article-title":"Antimicrobial resistance and management of invasive Salmonella disease","volume":"33","author":"Kariuki","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.tmaid.2020.101946_bib48","doi-asserted-by":"crossref","first-page":"209","DOI":"10.7883\/yoken.JJID.2017.321","article-title":"Report of relapse typhoid fever cases from Kolkata, India: recrudescence or reinfection?","volume":"71","author":"Samajpati","year":"2018","journal-title":"Jpn J Infect Dis"},{"issue":"1","key":"10.1016\/j.tmaid.2020.101946_bib49","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/S1473-3099(18)30350-5","article-title":"Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance","volume":"19","author":"Andrews","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101946_bib50","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/nyas.12490","article-title":"How multidrug resistance in typhoid fever affects treatment options","volume":"1323","author":"Tatavarthy","year":"2014","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"10.1016\/j.tmaid.2020.101946_bib51","doi-asserted-by":"crossref","first-page":"e1245","DOI":"10.1371\/journal.pntd.0001245","article-title":"Emergence of a globally dominant IncHI1 plasmid type associated with multiple drug resistant typhoid","volume":"5","author":"Holt","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"10.1016\/j.tmaid.2020.101946_bib52","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/tmi.12899","article-title":"Salmonella typhi genomics: envisaging the future of typhoid eradication","volume":"22","author":"Yap","year":"2017","journal-title":"Trop Med Int Health"},{"issue":"2","key":"10.1016\/j.tmaid.2020.101946_bib53","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/AAC.00645-08","article-title":"Variation in Salmonella enterica serovar typhi IncHI1 plasmids during the global spread of resistant typhoid fever","volume":"53","author":"Phan","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.tmaid.2020.101946_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006779","article-title":"A systematic review of antimicrobial resistance in Salmonella enterica serovar Typhi, the etiological agent of typhoid","volume":"12","author":"Britto","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.tmaid.2020.101946_bib55","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1038\/s41467-018-07370-z","article-title":"The phylogeography and incidence of multi-drug resistant typhoid fever in sub-Saharan Africa","volume":"9","author":"Park","year":"2018","journal-title":"Nat Commun"},{"issue":"Suppl 2","key":"10.1016\/j.tmaid.2020.101946_bib56","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1093\/cid\/ciy1111","article-title":"Antibiotic resistance and typhoid","volume":"68","author":"Dyson","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.tmaid.2020.101946_bib57","article-title":"Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever)","author":"Effa","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tmaid.2020.101946_bib58","author":"Janjua"},{"key":"10.1016\/j.tmaid.2020.101946_bib59","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.tmaid.2018.10.013","article-title":"Travellers take heed: outbreak of extensively drug resistant (XDR) typhoid fever in Pakistan and a warning from the US CDC","volume":"27","author":"Saleem","year":"2019","journal-title":"Trav Med Infect Dis"},{"issue":"52","key":"10.1016\/j.tmaid.2020.101946_bib60","article-title":"Disease outbreaks in Eastern Mediterranean Region (EMR), January to December 2018","volume":"11","year":"2018","journal-title":"Weekly Epidemiological Monitor"},{"key":"10.1016\/j.tmaid.2020.101946_bib61","author":"ProMED-mail"},{"key":"10.1016\/j.tmaid.2020.101946_bib62","series-title":"Antimicrobial resistance in typhoid: implications for policy and immunization strategies","author":"Bhutta","year":"2016"},{"issue":"10","key":"10.1016\/j.tmaid.2020.101946_bib63","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3855\/jidc.1192","article-title":"Factors associated with typhoid relapse in the era of multiple drug resistant strains","volume":"5","author":"Ahmad","year":"2011","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.tmaid.2020.101946_bib64","first-page":"Doc01","article-title":"Relapse of typhoid fever following delayed response to meropenem: a case report and review of previously published cases indicating limited clinical efficacy of meropenem for the treatment of typhoid fever","volume":"17","author":"Blumentrath","year":"2019","journal-title":"Ger Med Sci"},{"issue":"6","key":"10.1016\/j.tmaid.2020.101946_bib65","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/infdis\/157.6.1235","article-title":"Efficacy of ciprofloxacin in the treatment of chronic typhoid carriers","volume":"157","author":"Ferreccio","year":"1988","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.tmaid.2020.101946_bib66","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.3201\/eid2011.140525","article-title":"ESBL-producing Salmonella enterica serovar typhi in traveler returning from Guatemala to Spain","volume":"20","author":"Gonzalez-Lopez","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.tmaid.2020.101946_bib67","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3201\/eid1509.090567","article-title":"Salmonella enterica serovar Typhi with CTX-M beta-lactamase, Germany","volume":"15","author":"Pfeifer","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.tmaid.2020.101946_bib68","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/cid\/ciw232","article-title":"Changing patterns in enteric fever incidence and increasing antibiotic resistance of enteric fever isolates in the United States, 2008-2012","volume":"63","author":"Date","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.tmaid.2020.101946_bib69","doi-asserted-by":"crossref","first-page":"11","DOI":"10.15585\/mmwr.mm6801a3","article-title":"Emergence of extensively drug-resistant Salmonella Typhi infections among travelers to or from Pakistan - United States, 2016-2018","volume":"68","author":"Chatham Stephens","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"21","key":"10.1016\/j.tmaid.2020.101946_bib70","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.21.1900289","article-title":"Ceftriaxone-resistant Salmonella enterica serotype Typhi in a pregnant traveller returning from Karachi, Pakistan to Denmark, 2019","volume":"24","author":"Engsbro","year":"2019","journal-title":"Euro Surveill"},{"issue":"6","key":"10.1016\/j.tmaid.2020.101946_bib71","doi-asserted-by":"crossref","first-page":"286","DOI":"10.5694\/mja2.50316","article-title":"First reported case of extensively drug-resistant typhoid in Australia","volume":"211","author":"Howard-Jones","year":"2019","journal-title":"Med J Aust"},{"key":"10.1016\/j.tmaid.2020.101946_bib72","author":"World Health Organization"},{"key":"10.1016\/j.tmaid.2020.101946_bib73","first-page":"153","article-title":"Typhoid vaccines: WHO position paper \u2013 March 2018","volume":"93","author":"World Health Organization","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.tmaid.2020.101946_bib74","author":"Emergent BioSolutions"},{"key":"10.1016\/j.tmaid.2020.101946_bib75","author":"Pasteur"},{"key":"10.1016\/j.tmaid.2020.101946_bib76","author":"Pasteur"},{"key":"10.1016\/j.tmaid.2020.101946_bib77","author":"Biotech"},{"key":"10.1016\/j.tmaid.2020.101946_bib78","article-title":"Typhoid Vi conjugate vaccine I.P","author":"Bio-Med","year":"2017","journal-title":"Peda Typh"},{"key":"10.1016\/j.tmaid.2020.101946_bib79","author":"Emergent BioSolutions"},{"issue":"8541","key":"10.1016\/j.tmaid.2020.101946_bib80","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(87)90480-6","article-title":"Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation","volume":"329","author":"Levine","year":"1987","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.tmaid.2020.101946_bib81","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/infdis\/159.4.766","article-title":"Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area","volume":"159","author":"Ferreccio","year":"1989","journal-title":"J Infect Dis"},{"issue":"18","key":"10.1016\/j.tmaid.2020.101946_bib82","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1056\/NEJM198710293171801","article-title":"Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report","volume":"317","author":"Acharya","year":"1987","journal-title":"N Engl J Med"},{"issue":"8569","key":"10.1016\/j.tmaid.2020.101946_bib83","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(87)91316-X","article-title":"Protective activity of Vi capsular polysaccharide vaccine against typhoid fever","volume":"2","author":"Klugman","year":"1987","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.tmaid.2020.101946_bib84","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0264-410X(95)00186-5","article-title":"Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization","volume":"14","author":"Klugman","year":"1996","journal-title":"Vaccine"},{"issue":"10111","key":"10.1016\/j.tmaid.2020.101946_bib85","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.tmaid.2020.101946_bib86","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/21645515.2015.1117715","article-title":"Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph\u2122) in Indian children: school based cluster randomized study","volume":"12","author":"Mitra","year":"2016","journal-title":"Hum Vaccines Immunother"},{"issue":"8720","key":"10.1016\/j.tmaid.2020.101946_bib87","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0140-6736(90)92266-K","article-title":"Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial","volume":"336","author":"Levine","year":"1990","journal-title":"Lancet"},{"issue":"Suppl 3","key":"10.1016\/j.tmaid.2020.101946_bib88","doi-asserted-by":"crossref","first-page":"S552","DOI":"10.1093\/clinids\/11.Supplement_3.S552","article-title":"Progress in vaccines against typhoid fever","volume":"11","author":"Levine","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.tmaid.2020.101946_bib89","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1086\/518141","article-title":"Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica serovar paratyphi B","volume":"45","author":"Levine","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.tmaid.2020.101946_bib90","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1086\/381548","article-title":"Postmarketing safety surveillance for typhoid fever vaccines from the vaccine adverse event reporting system, July 1990 through June 2002","volume":"38","author":"Begier","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.tmaid.2020.101946_bib91","article-title":"Safety and immunogenicity of Salmonella typhi Vi conjugate vaccine (Peda Typh\u2122) in children upto five years","volume":"3","author":"Chinnasami","year":"2013","journal-title":"Int J Sci Res"},{"issue":"3","key":"10.1016\/j.tmaid.2020.101946_bib92","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.tmaid.2020.101946_bib93","first-page":"145","article-title":"Polio vaccines: WHO position paper - March, 2016","volume":"91","author":"World Health Organization","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.tmaid.2020.101946_bib94","author":"Emergent BioSolutions"},{"key":"10.1016\/j.tmaid.2020.101946_bib95","author":"Grand Lyon"},{"issue":"Suppl 1","key":"10.1016\/j.tmaid.2020.101946_bib96","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1093\/cid\/ciy884","article-title":"Overview of the typhoid conjugate vaccine pipeline: current status and future plans","volume":"68","author":"Sahastrabuddhe","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.tmaid.2020.101946_bib97","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines6030045","article-title":"Why is eradicating typhoid fever so challenging: implications for vaccine and therapeutic design","volume":"6","author":"Yang","year":"2018","journal-title":"Vaccines"},{"issue":"8774","key":"10.1016\/j.tmaid.2020.101946_bib98","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0140-6736(91)91910-M","article-title":"Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine","volume":"338","author":"Simanjuntak","year":"1991","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.tmaid.2020.101946_bib99","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/infdis\/145.3.292","article-title":"A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results","volume":"145","author":"Wahdan","year":"1982","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.tmaid.2020.101946_bib100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0264-410X(94)90194-5","article-title":"Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines","volume":"12","author":"Keitel","year":"1994","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1016\/j.tmaid.2020.101946_bib101","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0264-410X(99)00231-5","article-title":"Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine","volume":"17","author":"Levine","year":"1999","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.tmaid.2020.101946_bib102","first-page":"81","article-title":"Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial","volume":"8","author":"Black","year":"1990","journal-title":"Chilean Typhoid Committee. Vaccine."},{"issue":"4","key":"10.1016\/j.tmaid.2020.101946_bib103","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa0807521","article-title":"A cluster-randomized effectiveness trial of Vi typhoid vaccine in India","volume":"361","author":"Sur","year":"2009","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.tmaid.2020.101946_bib104","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1905047","article-title":"Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal","volume":"381","author":"Shakya","year":"2019","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.tmaid.2020.101946_bib105","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1016\/j.vaccine.2020.03.028","article-title":"Adverse events following immunization with typhoid conjugate vaccine in an outbreak setting in Hyderabad","volume":"38","author":"Qamar","year":"2020","journal-title":"Pakistan. Vaccine."},{"issue":"1","key":"10.1016\/j.tmaid.2020.101946_bib106","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/inthealth\/ihz069","article-title":"Re-evaluating herd protection by Vi typhoid vaccine in a cluster randomized trial","volume":"12","author":"Ali","year":"2020","journal-title":"Int Health"},{"key":"10.1016\/j.tmaid.2020.101946_bib107","author":"GlaxoSmithKline"},{"key":"10.1016\/j.tmaid.2020.101946_bib108","author":"NaTHNaC"},{"issue":"3","key":"10.1016\/j.tmaid.2020.101946_bib109","doi-asserted-by":"crossref","DOI":"10.1128\/MMBR.00007-17","article-title":"Vaccination against Salmonella infection: the mucosal way","volume":"81","author":"Gayet","year":"2017","journal-title":"Microbiol Mol Biol Rev"},{"issue":"5","key":"10.1016\/j.tmaid.2020.101946_bib110","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/infdis\/131.5.553","article-title":"Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine","volume":"131","author":"Germanier","year":"1975","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.tmaid.2020.101946_bib111","first-page":"E1","article-title":"Overview of the impact of typhoid and paratyphoid fever. Utility of Ty21a vaccine (Vivotif(\u00ae)","volume":"58","author":"Amicizia","year":"2017","journal-title":"J Prev Med Hyg"},{"key":"10.1016\/j.tmaid.2020.101946_bib112","series-title":"Plotkin\u2019s vaccines, 7th Edition","article-title":"Typhoid fever vaccines","author":"Levine","year":"2018"},{"key":"10.1016\/j.tmaid.2020.101946_bib113","first-page":"9","article-title":"Immunogenicity of Ty21a attenuated \"Salmonella typhi\" given with sodium bicarbonate or in enteric-coated capsules","volume":"53","author":"Black","year":"1983","journal-title":"Dev Biol Stand"},{"issue":"2","key":"10.1016\/j.tmaid.2020.101946_bib114","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/infdis\/163.2.336","article-title":"The human humoral immune response to Salmonella typhi Ty21a","volume":"163","author":"Forrest","year":"1991","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.tmaid.2020.101946_bib115","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1128\/iai.56.10.2731-2735.1988","article-title":"Comparative analysis of immunological responses to oral (Ty21a) and parenteral (TAB) typhoid vaccines","volume":"56","author":"D'Amelio","year":"1988","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.tmaid.2020.101946_bib116","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/0264-410X(93)90237-R","article-title":"Clinical and immunological response to typhoid vaccination with parenteral or oral vaccines in two groups of 30 recruits","volume":"11","author":"Nisini","year":"1993","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.tmaid.2020.101946_bib117","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/infdis\/151.3.482","article-title":"Demonstration of specific IgA in human feces after immunization with live Ty21a Salmonella typhi vaccine","volume":"151","author":"Cancellieri","year":"1985","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.tmaid.2020.101946_bib118","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4049\/jimmunol.158.2.574","article-title":"Homing potentials of circulating lymphocytes in humans depend on the site of activation: oral, but not parenteral, typhoid vaccination induces circulating antibody-secreting cells that all bear homing receptors directing them to the gut","volume":"158","author":"Kantele","year":"1997","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.tmaid.2020.101946_bib119","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/2249-4863.184616","article-title":"Vaccine epidemiology: a review","volume":"5","author":"Lahariya","year":"2016","journal-title":"J Fam Med Prim Care"},{"issue":"10","key":"10.1016\/j.tmaid.2020.101946_bib120","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1086\/342908","article-title":"Efficacy of atovaquone\/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines","volume":"35","author":"Faucher","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101946_bib121","author":"World Health Organization"},{"key":"10.1016\/j.tmaid.2020.101946_bib122","author":"World Health Organization"},{"issue":"1","key":"10.1016\/j.tmaid.2020.101946_bib123","article-title":"Low rate of spontaneously reported adverse drug reactions in a recent post-marketing surveillance for Vivotif Berna","volume":"6","author":"Griot-Wenk","year":"2001","journal-title":"Giorn Ital Med Trop"},{"issue":"4","key":"10.1016\/j.tmaid.2020.101946_bib124","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/1040841X.2016.1249335","article-title":"Vi capsular polysaccharide: synthesis, virulence, and application","volume":"43","author":"Hu","year":"2017","journal-title":"Crit Rev Microbiol"},{"issue":"36","key":"10.1016\/j.tmaid.2020.101946_bib125","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1016\/j.vaccine.2012.06.015","article-title":"Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan","volume":"30","author":"Khan","year":"2012","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.tmaid.2020.101946_bib126","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10654-005-7454-6","article-title":"Outbreak of typhoid fever in vaccinated members of the French armed forces in the ivory coast","volume":"20","author":"Michel","year":"2005","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"10.1016\/j.tmaid.2020.101946_bib127","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1586\/erv.11.8","article-title":"Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines","volume":"10","author":"Poolman","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"33","key":"10.1016\/j.tmaid.2020.101946_bib128","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1016\/j.vaccine.2015.05.080","article-title":"Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellers","volume":"33","author":"Roggelin","year":"2015","journal-title":"Vaccine"},{"issue":"23\u201324","key":"10.1016\/j.tmaid.2020.101946_bib129","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/S0264-410X(99)00167-X","article-title":"Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-Vi)","volume":"17","author":"Kroon","year":"1999","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.tmaid.2020.101946_bib130","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1093\/cid\/ciy878","article-title":"Introduction of typhoid conjugate vaccines in Africa and Asia","volume":"68","author":"Neuzil","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.tmaid.2020.101946_bib131","first-page":"13","article-title":"Global Advisory Committee on Vaccine Safety, 30 November - 1 December 2016","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"issue":"17","key":"10.1016\/j.tmaid.2020.101946_bib132","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2020.101946_bib133","article-title":"Coalition against typhoid","year":"2018","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.tmaid.2020.101946_bib134","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1473-3099(13)70241-X","article-title":"Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials","volume":"14","author":"Bhutta","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101946_bib135","series-title":"Paper presented at: 10th International Conference on Typhoid and Other Invasive Salmonelloses","article-title":"Progress in the development of Vi-CRM197 conjugate vaccine","author":"Goel","year":"2017"},{"key":"10.1016\/j.tmaid.2020.101946_bib136","author":"Clinicaltrialsgov"},{"key":"10.1016\/j.tmaid.2020.101946_bib137","author":"Clinicaltrialsgov"},{"issue":"2","key":"10.1016\/j.tmaid.2020.101946_bib138","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211784","article-title":"Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine","volume":"14","author":"Medise","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.tmaid.2020.101946_bib139","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijid.2020.01.045","article-title":"One-month follow up of a randomized clinical trial-phase II study in 6 to <24 months old Indonesian subjects: safety and immunogenicity of Vi-DT Typhoid Conjugate Vaccine","volume":"93","author":"Medise","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101946_bib140","doi-asserted-by":"crossref","first-page":"100540","DOI":"10.1016\/j.eclinm.2020.100540","article-title":"Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: phase II, randomized, dose-scheduling, observer-blind Study","volume":"27","author":"Capeding","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"3_Suppl","key":"10.1016\/j.tmaid.2020.101946_bib141","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4269\/ajtmh.18-0045","article-title":"Typhoid fever: tracking the trend in Nigeria","volume":"99","author":"Akinyemi","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2020.101946_bib142","article-title":"Background paper to SAGE on typhoid vaccine policy","author":"World Health Organization","year":"2017","journal-title":"Recommendations"},{"key":"10.1016\/j.tmaid.2020.101946_bib143","author":"World Health Organization"},{"issue":"Suppl 1","key":"10.1016\/j.tmaid.2020.101946_bib144","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1093\/cid\/ciy927","article-title":"Revised global typhoid vaccination policy","volume":"68","author":"Bentsi-Enchill","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"3_Suppl","key":"10.1016\/j.tmaid.2020.101946_bib145","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4269\/ajtmh.18-0139","article-title":"Longitudinal typhoid fever trends in India from 2000 to 2015","volume":"99","author":"Balaji","year":"2018","journal-title":"Am J Trop Med Hyg"},{"issue":"9817","key":"10.1016\/j.tmaid.2020.101946_bib146","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0140-6736(12)60294-3","article-title":"A first step in bringing typhoid fever out of the closet","volume":"379","author":"Maurice","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2020.101946_bib147","author":"Gavi the Vaccine Alliance"},{"issue":"1","key":"10.1016\/j.tmaid.2020.101946_bib148","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029119","article-title":"Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa","volume":"7","author":"Breiman","year":"2012","journal-title":"PloS One"},{"issue":"Suppl 2","key":"10.1016\/j.tmaid.2020.101946_bib149","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1093\/cid\/ciy1103","article-title":"Typhoid Vaccine Acceleration Consortium Malawi: a Phase III, randomized, double-blind, controlled trial of the clinical efficacy of typhoid conjugate vaccine among children in Blantyre, Malawi","volume":"68","author":"Meiring","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"10.1016\/j.tmaid.2020.101946_bib150","doi-asserted-by":"crossref","first-page":"S232","DOI":"10.1093\/infdis\/jix598","article-title":"Comparison of strategies and incidence thresholds for Vi conjugate vaccines against typhoid fever: a cost-effectiveness modeling study","volume":"218","author":"Lo","year":"2018","journal-title":"J Infect Dis"},{"issue":"50","key":"10.1016\/j.tmaid.2020.101946_bib151","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1016\/j.vaccine.2008.09.040","article-title":"The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries","volume":"26","author":"Cook","year":"2008","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.tmaid.2020.101946_bib152","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1016\/j.vaccine.2017.05.001","article-title":"Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings","volume":"35","author":"Antillon","year":"2017","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1016\/j.tmaid.2020.101946_bib153","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/cid\/ciy1108","article-title":"Predicting the impact of typhoid conjugate vaccines on antimicrobial resistance","volume":"68","author":"Kaufhold","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.tmaid.2020.101946_bib154","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.vaccine.2014.11.030","article-title":"Specific and cross-reactive immune response to oral Salmonella typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly","volume":"33","author":"Pakkanen","year":"2015","journal-title":"Vaccine"},{"issue":"3_Suppl","key":"10.1016\/j.tmaid.2020.101946_bib155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4269\/ajtmh.18-0111","article-title":"Typhoid fever: way forward","volume":"99","author":"Bhutta","year":"2018","journal-title":"Am J Trop Med Hyg"},{"issue":"9835","key":"10.1016\/j.tmaid.2020.101946_bib156","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1016\/S0140-6736(12)60436-X","volume":"379","author":"Harris","year":"2012","journal-title":"Cholera. Lancet."},{"issue":"4","key":"10.1016\/j.tmaid.2020.101946_bib157","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2471\/BLT.16.175166","article-title":"Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings","volume":"95","author":"Hsiao","year":"2017","journal-title":"Bull World Health Organ"},{"issue":"6","key":"10.1016\/j.tmaid.2020.101946_bib158","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2471\/BLT.17.207175","article-title":"Oral cholera vaccine in cholera prevention and control, Malawi","volume":"96","author":"M'Bangombe","year":"2018","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.tmaid.2020.101946_bib159","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.vaccine.2013.11.066","article-title":"Twenty-five years of the WHO vaccines prequalification programme (1987-2012): lessons learned and future perspectives","volume":"33","author":"Dellepiane","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101946_bib160","author":"Gavi the Vaccine Alliance"},{"key":"10.1016\/j.tmaid.2020.101946_bib161","author":"Gavi the Vaccine Alliance","year":"2019","journal-title":"Eligibility"},{"issue":"9","key":"10.1016\/j.tmaid.2020.101946_bib162","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1080\/21645515.2017.1333681","article-title":"A forecast of typhoid conjugate vaccine introduction and demand in typhoid endemic low- and middle-income countries to support vaccine introduction policy and decisions","volume":"13","author":"Mogasale","year":"2017","journal-title":"Hum Vaccines Immunother"},{"issue":"Suppl 2","key":"10.1016\/j.tmaid.2020.101946_bib163","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1093\/cid\/ciy1117","article-title":"The Coalition against Typhoid: mobilizing a community for a global fight","volume":"68","author":"Lindsay","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101946_bib164","author":"University of Maryland School of Medicine"},{"key":"10.1016\/j.tmaid.2020.101946_bib165","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tmaid.2018.06.007","article-title":"Stand-by antibiotics encourage unwarranted use of antibiotics for travelers' diarrhea: a prospective study","volume":"27","author":"Vilkman","year":"2019","journal-title":"Trav Med Infect Dis"},{"issue":"29","key":"10.1016\/j.tmaid.2020.101946_bib166","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1016\/j.vaccine.2014.04.055","article-title":"Effectiveness of typhoid vaccination in US travelers","volume":"32","author":"Mahon","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.tmaid.2020.101946_bib167","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/jtm.12178","article-title":"Effectiveness of the typhoid Vi vaccine in overseas travelers from England","volume":"22","author":"Wagner","year":"2015","journal-title":"J Trav Med"},{"issue":"4","key":"10.1016\/j.tmaid.2020.101946_bib168","doi-asserted-by":"crossref","first-page":"60","DOI":"10.14745\/ccdr.v40i04a01","article-title":"Summary of the statement on international travellers and typhoid by the Committee to Advise on Tropical Medicine and Travel (CATMAT)","volume":"40","author":"Greenaway","year":"2014","journal-title":"Can Comm Dis Rep"},{"key":"10.1016\/j.tmaid.2020.101946_bib169","author":"NaTHNaC"},{"issue":"11","key":"10.1016\/j.tmaid.2020.101946_bib170","first-page":"305","article-title":"Updated recommendations for the use of typhoid vaccine--Advisory Committee on Immunization Practices, United States, 2015","volume":"64","author":"Jackson","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.tmaid.2020.101946_bib172","author":"Government of Canada"},{"key":"10.1016\/j.tmaid.2020.101946_bib173","author":"Institut Pasteur"},{"key":"10.1016\/j.tmaid.2020.101946_bib174","author":"Fit for Travel - travel medical information service"},{"key":"10.1016\/j.tmaid.2020.101946_bib175","author":"Paul Ehrlich Institute"},{"key":"10.1016\/j.tmaid.2020.101946_bib176","author":"Sociedade Portuguesa De Medicina Do Viajante"},{"key":"10.1016\/j.tmaid.2020.101946_bib177","author":"Sociedade Portuguesa De Medicina Do Viajante"},{"key":"10.1016\/j.tmaid.2020.101946_bib178","author":"Tropical Medicine Bureau"},{"key":"10.1016\/j.tmaid.2020.101946_bib179","author":"Medicinesie"},{"key":"10.1016\/j.tmaid.2020.101946_bib180","author":"Fundaci\u00f3n IO"},{"key":"10.1016\/j.tmaid.2020.101946_bib181","author":"Asociaci\u00f3n Espa\u00f1ola de Vacunolog\u00eda"},{"key":"10.1016\/j.tmaid.2020.101946_bib183","author":"Office F\u00e9d\u00e9ral de la Sant\u00e9 Publique"},{"key":"10.1016\/j.tmaid.2020.101946_bib185","author":"NaTHNaC"},{"key":"10.1016\/j.tmaid.2020.101946_bib186","author":"Public Health England"},{"key":"10.1016\/j.tmaid.2020.101946_bib187","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.tmaid.2020.101946_bib188","author":"Health GSoTMaG"},{"key":"10.1016\/j.tmaid.2020.101946_bib189","author":"Coalition against Typhoid"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893920304439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893920304439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:05:50Z","timestamp":1761487550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893920304439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":186,"alternative-id":["S1477893920304439"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2020.101946","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Typhoid fever infection \u2013 Antibiotic resistance and vaccination strategies: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2020.101946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101946"}}